Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 3/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.69 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tenoxicam SCHEMBL19307296 | 0.99 | PTGS1 (0.98) | PTGS1KDM4EUSP2CYP2C9GAA | |
| Tenoxicam SCHEMBL1683529 | 0.95 | PTGS1 (0.90) | PTGS1KDM4EUSP2CYP2C9GAA | |
| Piroxicam SCHEMBL6846290 | 0.94 | PTGS1 (0.89) | PTGS1KDM4EUSP2CYP2C9GAA | |
| Lornoxicam SCHEMBL4745029 | 0.91 | ABCB11 (0.88) | PTGS1KDM4EUSP2CYP2C9GAA | |
| SCHEMBL14628817 | 0.89 | PTGS1 (0.80) | PTGS1KDM4EUSP2CYP2C9GAA | |
| SCHEMBL11473095 | 0.88 | PTGS1 (0.78) | PTGS1KDM4EUSP2CYP2C9GAA | |
| SCHEMBL13777309 | 0.87 | PTGS1 (0.77) | PTGS1KDM4EUSP2CYP2C9GAA | |
| Piroxicam SCHEMBL9114300 | 0.86 | PTGS1 (0.74) | PTGS1KDM4EUSP2CYP2C9GAA | |
| Piroxicam SCHEMBL1444687 | 0.86 | ABCB11 (0.79) | PTGS1KDM4EUSP2CYP2C9GAA | |
| SCHEMBL11485261 | 0.86 | PTGS1 (0.76) | PTGS1KDM4EUSP2CYP2C9GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 37316 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| US-20260130928-A1 | COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN | ASCENTAWITS PHARMACEUTICALS LTD (CN) | 2026-05-14 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-12605432-B2 | Combinations for antigen based therapy | DIAMYD MEDICAL AB (SE) | 2026-04-21 | — | — | US | claimed |
| US-20260069532-A1 | METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE | MEDINCELL S.A. (FR) | 2026-03-12 | — | — | US | claimed |
| US-12558309-B2 | Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue | MEDINCELL S.A. (FR) | 2026-02-24 | — | — | US | claimed |
| US-12534571-B2 | Amphiphilic block copolymer, preparation method thereof and nanomicelle drug-loading system | SHANGHAI BEST-LINK BIOSCIENCE, LLC (CN) | 2026-01-27 | — | — | US | claimed |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| EP-4665315-A1 | METHODS OF PREPARATION OF ZINGERONE, COMPOSITIONS COMPRISING ZINGERONE, AND USES THEREFOR | Evithe Limited (NZ) | 2025-12-24 | — | — | EP | claimed |
| EP-0270316-A2 | Topical compositions comprising 1-substituted imidazoles and NSAIDs for treatment of acne | PFIZER INC. (US) | 1988-06-08 | — | — | EP | claimed |
| US-4748174-A | NONSTEROIDAL ANTIINFLAMMATORY AND ANALGESIC DRUGS | THERAPICON S.R.L. (IT) | 1988-05-31 | — | — | US | claimed |
| WO-1987007506-A1 | METHODS AND COMPOSITIONS USING LIPOSOME-ENCAPSULATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | THE LIPOSOME COMPANY, INC. (US) | 1987-12-17 | — | — | WO | claimed |
| EP-0249561-A2 | Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs | THE LIPOSOME COMPANY, INC. (US) | 1987-12-16 | — | — | EP | claimed |
| US-4687766-A | MIXTURE OF OXICAM DERIVATIVES WITH PHOSPHOLIPID | A. NATTERMAN & CIE, GMBH (DE) | 1987-08-18 | — | — | US | claimed |
| US-4636498-A | OXICAMS, ANTIULCER, ANTISECRETORY 2-GUANIDINO-4-(4-IMIDAZOLYL) THIAZOLES | PFIZER INC. (US) | 1987-01-13 | — | — | US | claimed |
| EP-0196434-A1 | Process for the preparation of a composition based on a divided substance with a slight hydrosolubility | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1986-10-08 | — | — | EP | claimed |
| CN-86101476-A | Based on the preparation of compositions of forming by the fine separation active principle of low aqueous solubility | — | 1986-09-17 | — | — | CN | claimed |
| EP-0178121-A2 | Improved formulation of antiinflammatory drugs | PFIZER INC. (US) | 1986-04-16 | — | — | EP | claimed |
| EP-0147735-A2 | Pharmaceutical preparation for the therapeutic treatment of rheumatic diseases | A. Nattermann & Cie. GmbH (DE) | 1985-07-10 | — | — | EP | claimed |